Neonatal supraventricular tachycardia

Supraventricular tachycardia (SVT) is one of the most common conditions requiring emergency cardiac care in neonates. Atrioventricular reentrant tachycardia utilizing an atrioventricular bypass tract is the most common form of SVT presenting in the neonatal period. There is high likelihood for spont...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinivasan, Chandra, Balaji, Seshadri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904811/
https://www.ncbi.nlm.nih.gov/pubmed/31541680
http://dx.doi.org/10.1016/j.ipej.2019.09.004
_version_ 1783478059964301312
author Srinivasan, Chandra
Balaji, Seshadri
author_facet Srinivasan, Chandra
Balaji, Seshadri
author_sort Srinivasan, Chandra
collection PubMed
description Supraventricular tachycardia (SVT) is one of the most common conditions requiring emergency cardiac care in neonates. Atrioventricular reentrant tachycardia utilizing an atrioventricular bypass tract is the most common form of SVT presenting in the neonatal period. There is high likelihood for spontaneous resolution for most of the common arrhythmia substrates in infancy. Pharmacological agents remain as the primary therapy for neonates.
format Online
Article
Text
id pubmed-6904811
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69048112019-12-20 Neonatal supraventricular tachycardia Srinivasan, Chandra Balaji, Seshadri Indian Pacing Electrophysiol J Review Article Supraventricular tachycardia (SVT) is one of the most common conditions requiring emergency cardiac care in neonates. Atrioventricular reentrant tachycardia utilizing an atrioventricular bypass tract is the most common form of SVT presenting in the neonatal period. There is high likelihood for spontaneous resolution for most of the common arrhythmia substrates in infancy. Pharmacological agents remain as the primary therapy for neonates. Elsevier 2019-09-18 /pmc/articles/PMC6904811/ /pubmed/31541680 http://dx.doi.org/10.1016/j.ipej.2019.09.004 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Srinivasan, Chandra
Balaji, Seshadri
Neonatal supraventricular tachycardia
title Neonatal supraventricular tachycardia
title_full Neonatal supraventricular tachycardia
title_fullStr Neonatal supraventricular tachycardia
title_full_unstemmed Neonatal supraventricular tachycardia
title_short Neonatal supraventricular tachycardia
title_sort neonatal supraventricular tachycardia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904811/
https://www.ncbi.nlm.nih.gov/pubmed/31541680
http://dx.doi.org/10.1016/j.ipej.2019.09.004
work_keys_str_mv AT srinivasanchandra neonatalsupraventriculartachycardia
AT balajiseshadri neonatalsupraventriculartachycardia

Ejemplares similares